Mr Avraam C Karas, MD | |
8113 Harford Road, Suite 100, Parkville, MD 21234 | |
(410) 323-4041 | |
(410) 532-6155 |
Full Name | Mr Avraam C Karas |
---|---|
Gender | Male |
Speciality | Thoracic Surgery (cardiothoracic Vascular Surgery) |
Location | 8113 Harford Road, Suite 100, Parkville, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679646301 | NPI | - | NPPES |
003041400 | Medicaid | MD | |
32699001 | Other | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | D15633 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Avraam C Karas, MD 302 Wynell Court, Timonium, MD 21093 Ph: (410) 323-4041 | Mr Avraam C Karas, MD 8113 Harford Road, Suite 100, Parkville, MD 21234 Ph: (410) 323-4041 |
News Archive
The Methodist DeBakey Heart & Vascular Center recently received a generous gift to develop a national training center for surgical and interventional treatments for cardiovascular disease, the number one killer of Americans. The benefactor wishes to remain anonymous.
A University of Sydney study of ventilation strategies has shown that high-frequency oscillatory ventilation (HFOV) for preterm babies gives the same outcomes as conventional ventilation (CV).
Infants whose gut is colonised by E. coli bacteria early in life have a higher number of memory B cells in their blood, reveals a study of infants carried out at the Sahlgrenska Academy at the University of Gothenburg, Sweden.
A new study describes how a carbohydrate-binding protein, galectin-3, promotes angiogenesis, the growth of new blood vessels. Targeting the protein, scientists identified two approaches that significantly reduced angiogenesis in mice. These discoveries, published online August 16 in The Journal of Experimental Medicine, may lead to novel treatments for diseases caused by excessive angiogenesis, including age-related macular degeneration, cancer, and diabetes.
Provenge is one step closer to being covered by Medicare. An expert panel voted Wednesday to endorse the newly approved therapeutic vaccine for men with advanced prostate cancer.
› Verified 3 days ago